Smith & Wesson Brands, Inc.
SWBI Nasdaq Ordnance & Accessories, (No Vehicles/Guided Missiles) Financials FY2017βFY2026
What Smith & Wesson Brands, Inc. does
No business description yet.
- Legal name
- SMITH & WESSON BRANDS, INC.
- Fiscal year ends
- April 30, 2026
- Latest annual report
- 10-K Β· Jun 17, 2026
- Accession Β· CIK
- 0001193125-26-274254
0001092796
Revenue and margins
Smith & Wesson Brands, Inc. had $524M of revenue in fiscal 2026, up 10.4% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew β17.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $90.4M in fiscal 2026, 17.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Smith & Wesson Brands, Inc. returned $23.2M to shareholders in fiscal 2026, 26% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Smith & Wesson Brands, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $121M | $53.6M | $60.8M | $25.2M | $28.2M |
| Current ratio | 3.7x | 3.3x | 3.0x | 4.2x | 3.2x |
| Quick ratio | 3.7x | 3.3x | 3.0x | 4.2x | 3.2x |
| Total assets | $497M | $541M | $577M | $560M | $513M |
| Total liabilities | $137M | $157M | $178M | $187M | $136M |
| Shareholders' equity | $361M | $385M | $400M | $372M | $377M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 3 / 8 | 5 / 8 | 7 / 8 | 5 / 8 | 3 / 8 | 6 / 8 | 3 / 8 | 7 / 8 |
| Accruals ratio | 0.5% | β5.4% | β5.1% | β20.8% | β10.8% | 12.0% | 3.9% | β11.7% | 3.6% | β17.9% |
| Altman Z'' | 5.67 | 4.81 | 5.15 | 5.55 | 10.84 | 12.62 | 8.81 | 8.17 | 7.95 | 7.79 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $903M | $607M | $481M | $530M | $1.1B | $864M | $479M | $536M | $475M | $524M |
| Gross profit | $375M | $196M | $146M | $166M | $449M | $375M | $155M | $158M | $127M | $141M |
| Research and development | $10.2M | $11.4M | $8.0M | $7.4M | $7.5M | $7.3M | $7.6M | $7.3M | $9.6M | $10.3M |
| Operating income | $200M | $27.0M | $43.5M | $50.3M | $320M | $252M | $48.4M | $47.1M | $23.9M | $29.2M |
| Pretax income | $191M | $17.6M | $34.2M | $39.2M | $318M | $252M | $48.2M | $51.7M | $19.2M | $25.1M |
| Income tax | $63.5M | β$2.5M | $9.3M | $11.5M | $74.4M | $57.9M | $11.4M | $10.4M | $5.8M | $6.6M |
| Net income | $128M | $20.1M | $18.4M | β$61.2M | $252M | $194M | $36.9M | $41.4M | $13.4M | $18.5M |
| Diluted EPS | $2.25 | $0.37 | $0.33 | β$1.10 | $4.55 | $4.08 | $0.80 | $0.89 | $0.30 | $0.41 |
| Diluted shares | 0.06B | 0.05B | 0.06B | 0.06B | 0.06B | 0.05B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $124M | $61.6M | $57.1M | $94.7M | $315M | $138M | $16.7M | $107M | β$7.2M | $114M |
| Capital expenditure | $34.9M | $18.5M | $30.9M | $12.4M | $22.1M | $24.0M | $89.6M | $90.8M | $21.6M | $23.7M |
| Free cash flow | $88.7M | $43.2M | $26.2M | $82.3M | $293M | $114M | β$72.8M | $16.0M | β$28.8M | $90.4M |
| Depreciation and amortization | $50.2M | $52.1M | $29.0M | $32.0M | $31.6M | $30.1M | $31.4M | $32.6M | $31.8M | $31.3M |
| Stock-based compensation | $8.6M | $7.8M | $6.9M | $2.4M | $4.7M | $4.5M | $5.1M | $5.7M | $7.6M | $8.4M |
| Acquisitions | $211M | $23.1M | $1.8M | β | β | β | β | β | β | β |
| Share buybacks | $50.1M | β | β | $0.0M | $110M | $90.0M | $0.0M | $10.2M | $25.5M | $0.0M |
| Dividends paid | β | β | β | $0.0M | $8.2M | $15.0M | $18.3M | $22.0M | $23.1M | $23.2M |
| Dividends and buybacks | $50.1M | β | β | $0.0M | $118M | $105M | $18.3M | $32.2M | $48.6M | $23.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $61.5M | $48.9M | $41.0M | $125M | $113M | $121M | $53.6M | $60.8M | $25.2M | $28.2M |
| Finance lease liabilities | β | β | β | $40.9M | $39.9M | $38.8M | $38.4M | $37.0M | $35.4M | $34.0M |
| Current assets | $318M | $270M | $299M | $393M | $268M | $328M | $292M | $287M | $277M | $241M |
| Current liabilities | $151M | $101M | $111M | $130M | $126M | $88.9M | $87.2M | $94.4M | $66.6M | $75.4M |
| Property and equipment, net | $150M | $159M | $183M | $157M | β | β | β | β | β | β |
| Goodwill | $169M | $191M | $182M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M |
| Intangible assets | $141M | $113M | $91.8M | $4.4M | $4.4M | $3.6M | $3.6M | $2.6M | $2.4M | $2.0M |
| Total assets | $788M | $745M | $767M | $730M | $446M | $497M | $541M | $577M | $560M | $513M |
| Total liabilities | $395M | $323M | $322M | $342M | $180M | $137M | $157M | $178M | $187M | $136M |
| Preferred stock | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $393M | $422M | $444M | $387M | $266M | $361M | $385M | $400M | $372M | $377M |
| Margins | ||||||||||
| Gross margin | 41.5% | 32.3% | 30.4% | 31.3% | 42.4% | 43.3% | 32.2% | 29.5% | 26.8% | 26.9% |
| Operating margin | 22.1% | 4.5% | 9.0% | 9.5% | 30.2% | 29.1% | 10.1% | 8.8% | 5.0% | 5.6% |
| EBITDA margin | 27.7% | 13.0% | 15.1% | 15.5% | 33.2% | 32.6% | 16.7% | 14.9% | 11.7% | 11.6% |
| Net margin | 14.2% | 3.3% | 3.8% | β11.6% | 23.8% | 22.5% | 7.7% | 7.7% | 2.8% | 3.5% |
| FCF margin | 9.8% | 7.1% | 5.4% | 15.5% | 27.7% | 13.2% | β15.2% | 3.0% | β6.1% | 17.3% |
| Returns | ||||||||||
| Return on capital employed | 31.4% | 4.2% | 6.6% | 8.4% | 99.7% | 61.6% | 10.7% | 9.8% | 4.8% | 6.7% |
| Return on equity | 32.5% | 4.9% | 4.2% | β14.7% | 77.1% | 62.0% | 9.9% | 10.5% | 3.5% | 4.9% |
| Return on assets | 16.2% | 2.6% | 2.4% | β8.2% | 42.9% | 41.2% | 7.1% | 7.4% | 2.4% | 3.4% |
| Return on tangible equity | 154.4% | 17.0% | 10.8% | β16.8% | 103.7% | 57.6% | 10.2% | 10.9% | 3.8% | 5.2% |
| Growth | ||||||||||
| Revenue growth | β | β32.8% | β20.7% | 10.0% | 100.0% | β18.4% | β44.5% | 11.8% | β11.4% | 10.4% |
| Net income growth | β | β84.3% | β8.5% | β432.6% | β | β22.8% | β81.0% | 12.2% | β67.5% | 37.7% |
| EPS growth | β | β83.6% | β10.8% | β433.3% | β | β10.3% | β80.4% | 11.3% | β66.3% | 36.7% |
| FCF growth | β | β51.3% | β39.3% | 214.1% | 256.4% | β61.2% | β164.0% | β | β280.4% | β |
| Share count change | β | β3.6% | 0.7% | 0.8% | β0.6% | β13.8% | β99.9% | 0.0% | β2.8% | 0.0% |
| Financial health | ||||||||||
| Current ratio | 2.1x | 2.7x | 2.7x | 3.0x | 2.1x | 3.7x | 3.3x | 3.0x | 4.2x | 3.2x |
| Quick ratio | 2.1x | 2.7x | 2.7x | 3.0x | 2.1x | 3.7x | 3.3x | 3.0x | 4.2x | 3.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 3.0% | 6.4% | 2.3% | 2.1% | 2.8% | 18.7% | 16.9% | 4.6% | 4.5% |
| Stock comp / revenue | 1.0% | 1.3% | 1.4% | 0.4% | 0.4% | 0.5% | 1.1% | 1.1% | 1.6% | 1.6% |
| Payouts / FCF | 56.4% | β | β | 0.0% | 40.3% | 92.3% | β | 201.7% | β | 25.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 3.0 | 5.0 | 7.0 | 5.0 | 3.0 | 6.0 | 3.0 | 7.0 |
| Altman Z'' | 5.7 | 4.8 | 5.1 | 5.5 | 10.8 | 12.6 | 8.8 | 8.2 | 7.9 | 7.8 |
| Accruals ratio | 0.5% | β5.4% | β5.1% | β20.8% | β10.8% | 12.0% | 3.9% | β11.7% | 3.6% | β17.9% |
Source: SEC EDGAR XBRL filings (CIK 0001092796). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.